Sean Christensen, MD, PhD, FAAD
SESSIONS
F075 Skin Disease in Transplant Recipients and Immunosuppressed Patients
Mar 9, 2024
•
3:30 PM - 12:00 AM
•
Room 24C
HANDOUTS
Login to view handouts
DISCLOSURES
Castle Biosciences – Advisory Board(Honoraria); inhibitor therapeutics – Advisory Board(No Compensation Received); Sol-Gel Technologies – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria);